Madrigal Pharmaceuticals Q1 2026 Earnings Preview
Source: SeekingAlpha
2026-05-05 12:04:42 ET
More on Madrigal Pharmaceuticals
- Madrigal Pharmaceuticals: Boom Or Bust In MASH? Regretfully, I'm Bearish
- Madrigal: The Easiest Money May Have Been Made
- Madrigal Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Most shorted large cap stocks as of mid-April
- Trump imposes tariffs on drugmakers who haven't signed MFN deals
Read the full article on Seeking Alpha
For further details see:
Madrigal Pharmaceuticals Q1 2026 Earnings Preview
Madrigal Pharmaceuticals Inc.
NASDAQ: MDGL
MDGL Trading
2.23% G/L:
$475.43 Last:
102,868 Volume:
$450.61 Open:
MDGL Latest News
June 03, 2026 08:00:00 am
Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026
May 27, 2026 08:00:00 am
Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH
MDGL Stock Data
$10,921,013,421
11,446,556
2.73%
146
N/A
Biotechnology & Life Sciences
Healthcare
US
West Conshohocken
